Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0002 USD | +100.00% | 0.00% | -50.00% |
2023 | Q BioMed Inc. Reports Earnings Results for the First Quarter Ended February 28, 2023 | CI |
2023 | Q BioMed Inc. Reports Earnings Results for the Full Year Ended November 30, 2022 | CI |
Sales 2021 | 0.2 15.66 | Sales 2022 | 0.28 22.76 | Capitalization | 1.35M 108M |
---|---|---|---|---|---|
Net income 2021 | -8M -640M | Net income 2022 | -2M -160M | EV / Sales 2021 | 79,967,019 x |
Net Debt 2021 | 2.71M 217M | Net Debt 2022 | 4.06M 325M | EV / Sales 2022 | 19,023,098 x |
P/E ratio 2021 |
-1.39
x | P/E ratio 2022 |
-0.2
x | Employees | - |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 97.01% |
1 day | +100.00% | ||
Current month | -33.33% | ||
1 month | -33.33% | ||
3 months | -75.00% | ||
6 months | -80.00% | ||
Current year | -50.00% |
Managers | Title | Age | Since |
---|---|---|---|
Denis Corin
CEO | Chief Executive Officer | 51 | 20/04/15 |
Ari Jatwes
DFI | Director of Finance/CFO | - | - |
Director/Board Member | 55 | 31/05/15 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 55 | 31/05/15 | |
Denis Corin
CEO | Chief Executive Officer | 51 | 20/04/15 |
Rick Panicucci
BRD | Director/Board Member | 63 | 12/02/18 |
1st Jan change | Capi. | |
---|---|---|
-50.00% | 29.02K | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.74B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- QBIO Stock